about
Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaPhase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis
P50
name
Eric Wenzel
@ast
Eric Wenzel
@en
Eric Wenzel
@es
Eric Wenzel
@nl
type
label
Eric Wenzel
@ast
Eric Wenzel
@en
Eric Wenzel
@es
Eric Wenzel
@nl
prefLabel
Eric Wenzel
@ast
Eric Wenzel
@en
Eric Wenzel
@es
Eric Wenzel
@nl